| Home | Search Abstracts | Browse Sessions | Program Committee | E-mail Abstract Author | View Session |
|
|
|
Session 99
Poster Abstracts Pathogenetic Mechanisms of Abnormalities of Glucose, Insulin, Lipid, and Mitochondrial Metabolism Monday, 1:30 - 3:30 pm Poster Hall |
Background: The
reversibility of mitochondrial dysfunction in ART-associated lipoatrophy (LA)
has not been investigated. We previously reported significant improvements in subcutaneous fat mitochondrial DNA (mtDNA)
levels, adipocyte apoptosis scores and DEXA-measured fat content in 16 subjects
who substituted abacavir (ABC) or zidovudine (ZDV) for stavudine (d4T). To
assess the effect of this strategy on mitochondrial function, we measured
activities of electron transport chain in skeletal muscle before and 48 weeks after
the switch of d4T to ABC or ZDV.
Methods: Skeletal muscle samples were obtained under heavy sedation with local
anesthetic injected only above the fascia, so not to impair electron transport chain
activities.
Samples were immediately frozen at -70 C, until analyzed. Electron transport chain
activities were measured using CLIA validated methods.
Results: We enrolled 16 subjects: 14 replaced d4T with ABC and 2 with ZDV. Muscle from 49 HIV-uninfected donors in the same
age range of the patients was used as control. At study entry, the mean values for electron transport chain assays, which measure the activity in complexes I through IV, ranged
from 48% to 85% of the mean levels observed in the
control samples. In particular, 7/16 patients had significant mitochondrial
respiratory chain dysfunction, with marked deficiencies in at least 2 of the
enzymes. The most consistent decreases in enzyme activities were associated
with complexes I, III, and citrate synthase, the latter reflecting a quantitative
loss of mitochondrial mass. At Week 48, there was significant improvement in
activity of Complex I as expressed in nmol/min/mg protein (mean ± SD; 0.9±0.6 at week 48 vs
0.6±0.5 at study entry; p = 0.020)
but surprisingly significant worsening in activity of Complex III as expressed
in nmol/min/mg protein (mean ± SD; 6.0±3.9 at week 48 vs 12.3±5.5 at study
entry; p = 0.027). Other enzyme
activities remained unchanged.
Conclusions: Despite improvement
in fat content, mtDNA levels and fat apoptosis, only a partial improvement of
mitochondrial function was seen 48 weeks after substitution of ABC or ZDV for
d4T. This could be due to the fact that severe mitochondrial dysfunction may be partially irreversible or take longer
than 48 weeks to reverse, or mtDNA
depletion may not be the sole mechanism involved in the NRTI-induced
mitochondrial dysfunction. Due to the
small sample size these results should be confirmed.
Keywords: lipodystrophy; mitochondrial toxicity; lipoatrophy
